Incyte Corporation (INCY) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Incyte Corporation  (NASDAQ: INCY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Incyte's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Incyte's ROI in the first quarter of 2026?
Incyte Corporation achieved a return on average invested assets (ROI) of 27.5 % in its first quarter of 2026, this is above INCY's average return on investment of 6.37%.
Incyte Corporations investments during the 12 months ending in the first quarter of 2026 are valued at $5 billion

ROI has improved compared to 27.08% in the fourth quarter of 2025, due to net income growth.

Within the Healthcare sector 2 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 48, from total ROI ranking in the fourth quarter of 2025 at 59.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 42 % 16.05 % -4.14 % -20.05 % -32.2 %
Y / Y Net Income Change TTM 6631.44 % 3844.96 % - - -87.45 %
Investment (TTM) in Millions 5,849 5,443 4,992 4,543 4,029
Return On Investment (TTM) 27.5 % 27.08 % 27.38 % 21.93 % 0.58 %
INCY's Overall Ranking # 48 # 59 # 25 # 79 # 1978
Seq. Investment Change TTM 9.58 % 9.45 % 9.32 % 8.3 % -10.44 %
Seq. Net Income Change TTM 11.28 % 8.25 % 36.48 % 3994.36 % -34.78 %
Net Income (TTM) in Millions 1,432 1,287 1,189 871 21

INCY Company Profile >> Back to INCY Roi Comparisons >> See Annual INCY Return On Investment



Return On Investment INCY's Ranking
Within: No.
Industry # 1
Sector # 3
Overall # 48

Return On Investment Statistics
High Average Low
40.25 %
6.37 %
-112.28 %
(June 30. 2015)   (Sep. 30, 2015)







Financial Statements
Incyte's I. Quarter Investments $ 5,849 Millions INCY's Balance sheet
Incyte's I. Quarter Income $ 303 Millions Quarterly INCY's Income Statement
INCY's Income by Division See INCY's Income by Division


INCY Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 5,443 3,802 5,542 4,684 4,047
Y / Y Investment Growth 43.14 % -31.38 % 18.31 % 15.73 % 39.7 %
Net Income in Millions 1,287 33 598 341 949
Y / Y Net Income Growth 3844.96 % -94.54 % 75.42 % -64.09 % -
Annual Return On Investment 23.64 % 0.86 % 10.78 % 7.27 % 23.44 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 23.64 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INCY's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INCY's Competitors
Subscribers only: Roi for Incyte's Suppliers
Subscribers only: Return On Investment for INCY's Customers

Other Ratios
INCY's Roa INCY's Inventory Turnover Ratio INCY's Growth Rates INCY's Dividend Statistics
INCY's Profitability Ratios INCY's Asset Turnover Ratio INCY's Dividend Growth
INCY's Roe INCY's Valuation Ratios INCY's Financial Strength Ratios INCY's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Ironwood Pharmaceuticals inc   72.86 %
Lensar Inc   71.13 %
Fortress Biotech Inc   70.93 %
Earth Science Tech Inc   68.75 %
Q32 Bio Inc   58.17 %
Oramed Pharmaceuticals Inc  54.33 %
Aurinia Pharmaceuticals Inc   54.02 %
Vaxart Inc   51.45 %
Escalon Medical Corp   51.07 %
Tg Therapeutics Inc   50.62 %
Zevra Therapeutics Inc   50.45 %
Idexx Laboratories Inc  50.05 %
Theravance Biopharma inc   43.85 %
Elite Pharmaceuticals Inc   43.22 %
Dariohealth Corp   40.59 %
Innoviva Inc   36.71 %
Indivior Pharmaceuticals Inc   36.55 %
Eli Lilly And Company  36.13 %
Abeona Therapeutics Inc   35.03 %
Lifemd Inc   34.80 %
Acadia Pharmaceuticals Inc   34.03 %
Mettler toledo International Inc   33.62 %
Adma Biologics Inc   30.38 %
Medpace Holdings Inc   30.34 %
Spero Therapeutics Inc   29.59 %
Rafael Holdings Inc  28.08 %
Incyte Corporation  27.50 %
Carlisle Companies Incorporated  24.39 %
Iradimed Corporation  23.59 %
Catalyst Pharmaceuticals Inc   23.58 %

Date modified: 2026-09-12T06:11:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.